Your Search Returned 7 tagged news reports
When you have fibromyalgia you live with chronic widespread pain and tenderness,which may never go away. There is good news: Cymbalta has been approved by the FDA to help manage the pain of fibromyalgia. Taking it just once every day can reduce the...
Tags: fibromyalgia, chronic pain, tenderness, Cymbalta, FDA, proved, pain, widespread, health, doctor, medicine
Coming out about health may sound like a funny title, but this is no laughing matter. Fibromyalgia is a very real condition. It effects more people than anyone knows, and more women than men have the condition. It takes more tests than cancer to detect....
Tags: health, fibro, fibromyalgia, coming out, pain, tired, lycra, cymbalta, magic wand, hurt, walk, run, crawl, life
Drugmaker Eli Lilly and Co. has resubmitted an application to have its antidepressant Cymbalta approved as a treatment for chronic pain. Cymbalta, the Indianapolis drugmaker's second best seller after the anti-psychotic Zyprexa, had withdrawn its marketing...
Tags: Cymbalta, chronic pain, lilly resubmitted, Eli Lilly and Co., resubmitted application
Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009. Eli Lilly had filed a supplemental new drug application, asking...
Tags: Eli Lilly and Co., Cymbalta, chronic pains
Food and Drug Administration to allow the use of Cymbalta for treatment of low back pain...Cymbalta, launched in 2004 by the Indianapolis-based drugmaker as an antidepressant but quickly tapped for other uses, offered relief to chronic low back pain sufferers,...
Tags: Cymbalta, Eli Lilly and Co.
Lilly gets OK from FDA to treat fibromyalgia Indianapolis drugmaker Eli Lilly and Co. has received governmental approval to use its anti-depression drug Cymbalta on a new class of patients: those with fibromyalgia...Food and Drug Administration gave its...
Tags: Cymbalta, Eli Lilly and Co.
Eli Lilly says first-quarter profit doubled on strong growth in sales of depression treatment Cymbalta and impotence drug Cialis, as well as fewer charges. Indianapolis-based Eli Lilly and Co. says earnings jumped to $1.06 billion, or 97 cents per share,...
Tags: Eli Lilly and Co., Cymbalta, Cialis, Merck & Co.